Opinion/decision on a Paediatric investigation plan (PIP): Ebglyss, Lebrikizumab, decision type: W: decision granting a waiver in all age groups for all conditions or indications, therapeutic area: Respiratory, thoracic and mediastinal disorders, PIP number: P/0212/2024

Opinion/decision on a Paediatric investigation plan (PIP): Ebglyss, Lebrikizumab, decision type: W: decision granting a waiver in all age groups for all conditions or indications, therapeutic area: Respiratory, thoracic and mediastinal disorders, PIP number: P/0212/2024

Jun 24, 2025 - 16:30
 0
Opinion/decision on a Paediatric investigation plan (PIP): Ebglyss, Lebrikizumab, decision type: W: decision granting a waiver in all age groups for all conditions or indications, therapeutic area: Respiratory, thoracic and mediastinal disorders, PIP number: P/0212/2024
Opinion/decision on a Paediatric investigation plan (PIP): Ebglyss, Lebrikizumab, decision type: W: decision granting a waiver in all age groups for all conditions or indications, therapeutic area: Respiratory, thoracic and mediastinal disorders, PIP number: P/0212/2024